Fred Alger Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-107,318	Closed	-$2.55M	–	546
2023 Q2	$2.55M	Sell	107,318 -216,358	-67%	-$5.15M	0.01%	313
2023 Q1	$8.23M	Sell	323,676 -104,597	-24%	-$2.66M	0.04%	213
2022 Q4	$12.5M	Buy	428,273 +167,190	+64%	+$4.88M	0.07%	192
2022 Q3	$5.36M	Buy	+261,083	New	+$5.36M	0.03%	253